Triple-Negative Breast Cancer (TNBC) is characterized by a lack of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth receptor 2 (HER-2) that are commonly found in breast cancer, and accounts for approximately 15% - 20% of all breast cancer cases 2. Here, ESR1 is linked to triple-negative breast carcinoma.